Silence Therapeutics Ratios (2019-2025) | SLN

Ratios Jun2019 Dec2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin -17.25%38.98%51.11%32.43%34.98%40.19%60.24%35.44%28.98%19.01%85.50%68.90%42.57%35.87%82.16%-322.13%-142.92%91.95%61.97%62.05%59.75%
EBT Margin -479.88%-561.71%-313.93%-470.49%-381.84%-328.85%-167.28%-368.38%-276.65%-315.84%-158.41%-131.92%-381.02%-713.01%-13.17%-2,440.88%-2,369.49%49.90%-20,091.55%-12,207.14%-13,180.50%
EBIT Margin -481.29%-515.39%-297.11%-478.60%-389.23%-329.91%-173.40%-386.74%-404.06%-230.03%-151.86%-125.85%-453.86%-633.59%-35.55%-2,923.50%-2,002.47%-17.20%-20,006.34%-10,697.77%-16,505.66%
EBITDA Margin -481.29%-515.39%-297.11%-478.60%-389.23%-329.91%1.36%-386.74%-404.06%-230.03%-0.49%-125.85%-453.86%-633.59%-35.55%-2,923.50%-2,002.47%-17.20%-20,006.34%-10,697.77%-16,505.66%
Operating Margin -481.29%-515.39%-297.11%-478.60%-389.23%-329.91%-173.40%-386.74%-404.06%-230.03%-151.86%-125.85%-453.86%-633.59%-35.55%-2,923.50%-2,002.47%-17.20%-20,006.34%-10,697.77%-16,505.66%
Net Margin -479.88%-561.71%-313.93%-470.49%-381.84%-328.85%-167.28%-368.38%-276.65%-315.84%-158.41%-131.92%-381.02%-713.01%-14.73%-2,469.38%-2,372.76%48.61%-20,091.55%-12,211.61%-13,181.13%
FCF Margin -312.12%-359.28%-384.64%963.75%-156.12%-64.59%-251.24%-226.96%-278.97%-281.39%-95.70%-164.28%-174.12%-861.22%-58.24%-686.75%-1,713.68%-108.84%-8,671.13%-9,749.55%-6,857.23%
Efficiency
Assets Average 193.97M175.27M156.01M
Equity Average 30.91M30.59M27.82M17.02M8.42M23.03M89.38M130.36M123.38M103.45M84.11M
Invested Capital 34.94M26.88M34.30M11.96M33.08M22.55M11.49M5.35M25.89M20.17M21.99M156.76M126.70M134.02M112.74M94.16M74.06M
Asset Utilization Ratio 0.140.160.17
Leverage & Solvency
Interest Coverage Ratio 34.94M26.88M34.30M11.96M33.08M22.55M11.49M5.35M25.89M20.17M15.34M25.33M21.16M157.17M142.01M122.80M
Equity Ratio 0.180.660.610.570.50
Valuation
Enterprise Value -14.81M-17.38M-12.82M434.13M536.49M575.98M624.89M515.89M615.79M489.07M289.73M194.34M483.07M166.00M160.90M280.62M565.93M712.28M697.05M769.16M177.50M-74.98M87.32M122.78M
Market Capitalization 452.09M574.71M638.67M726.55M616.48M714.92M568.63M354.66M300.43M547.37M222.80M198.09M355.11M671.69M855.69M835.24M849.66M324.83M133.17M273.93M245.14M
Return Ratios
Return on Sales -4.43%-4.20%-3.70%-3.06%-2.90%-2.68%-2.67%-2.55%-1.93%-2.04%-2.29%-1.49%-2.39%-3.70%-1.05%-2.58%-2.91%-2.50%
Return on Capital Employed -0.49%-0.54%-0.60%
Return on Assets -0.37%-0.45%-0.41%
Return on Equity -2.35%-3.71%-7.40%-2.65%-0.55%-0.35%-0.58%-0.76%-0.77%